Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:511-515

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y.
Right arrow Articles by Lonigro, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y.
Right arrow Articles by Lonigro, A. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*12-O-TETRADECANOYLPHORBOL-13-ACETATE

(Hypertension. 1998;31:511.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Vascular Endothelial Growth Factor mRNA in Pericytes Is Upregulated by Phorbol Myristate Acetate

Yang Kim; Riffat Y. Imdad; Alan H. Stephenson; Randy S. Sprague; Andrew J. Lonigro

From the Departments of Internal Medicine and Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, MO.

Correspondence to Andrew J. Lonigro, MD, Saint Louis University, School of Medicine. 1402 South Grand Blvd, St. Louis, MO 63104. E-mail Lonigro{at}slu.edu

Increased microvascular permeability, which occurs in conditions such as the adult respiratory distress syndrome and diabetes mellitus, is related to physicochemical alterations in the microvascular barrier. We postulate that, in part, capillary pericytes affect microvascular permeability via production of a vasoactive cytokine, viz, vascular endothelial growth factor (VEGF), also known as vascular permeability factor. The goal of the present study was to evaluate the effects of phorbol myristate acetate (PMA), a substance known to produce nonhydrostatic pulmonary edema in intact animals, on VEGF gene expression in pericyte cultures. Microvascular pericytes were isolated from bovine retinas using magnetic microspheres coated with 3G5 monoclonal antibody. Pericyte identity was confirmed both morphologically and by immunostaining for {alpha}-smooth muscle actin and 3G5 ganglioside. The cultured pericytes were stimulated with N{omega}-nitro-L-arginine methyl ester (L-NAME, 1x10-4 mmol/L), angiotensin II (1x10-6 mmol/L), and PMA (5x10-8 mmol/L), selected because of their ability to upregulate VEGF mRNA expressions in other cell types. Northern blot analysis was performed using [32P]dCTP labeled human VEGF cDNA (Genentech). Lane-loading differences were normalized using mouse GAPDH control cDNA probe. VEGF mRNA expression was upregulated by PMA (10-9 to 10-6 mol/L) in a dose-dependent manner, whereas neither L-NAME nor angiotensin II affected VEGF mRNA expression in pericytes. These results support the hypothesis that pericytes increase permeability of the endothelial barrier through increased VEGF production.


Key Words: pericytes • vascular endothelial growth factor • microvascular permeability • phorbol myristate acetate • 3G5 monoclonal antibody

Abbreviations: Ang II = angiotensin II • L-NAME = N{omega}-nitro-L-arginine methyl ester • PMA = phorbol myristate acetate • VEGF = vascular endothelial growth factor




This article has been cited by other articles:


Home page
Infect. Immun.Home page
S. I. Resto-Ruiz, M. Schmiederer, D. Sweger, C. Newton, T. W. Klein, H. Friedman, and B. E. Anderson
Induction of a Potential Paracrine Angiogenic Loop between Human THP-1 Macrophages and Human Microvascular Endothelial Cells during Bartonella henselae Infection
Infect. Immun., August 1, 2002; 70(8): 4564 - 4570.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R. K. Jain, and D. M. McDonald
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Am. J. Pathol., March 1, 2002; 160(3): 985 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Nadal, G. M. Scicli, L. A. Carbini, and A. G. Scicli
Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H739 - H748.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Otani, H. Takagi, H. Oh, K. Suzuma, M. Matsumura, E. Ikeda, and Y. Honda
Angiotensin II-Stimulated Vascular Endothelial Growth Factor Expression in Bovine Retinal Pericytes
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1192 - 1199.
[Abstract] [Full Text]